Retour sur lavenir.net
   XIOR 27.950 € (-0,53 %)     LOTUS BAKERIES 10 800.000 € (-1,46 %)     CARE PROPERTY INV. 12.640 € (-0,16 %)     KINEPOLIS GROUP 38.650 € (-0,39 %)     KBC ANCORA 87.200 € (+2,71 %)     EKOPAK 3.710 € (-7,25 %)     MONTEA 67.900 € (-0,73 %)     ARGENX SE 760.200 € (+0,88 %)     AB INBEV 71.480 € (+0,42 %)     NYXOAH 1.384 € (+0,73 %)     AGFA-GEVAERT 0.395 € (+3,82 %)     PROXIMUS 6.060 € (-1,14 %)     CENERGY 21.260 € (+4,52 %)     DEME GROUP 168.800 € (-0,35 %)     CFE 11.450 € (+1,33 %)     BARCO 7.795 € (+0,19 %)     BEKAERT 41.250 € (+0,61 %)     VGP 81.100 € (+1,37 %)     SOLVAY 25.980 € (+0,70 %)     D'IETEREN GROUP 172.400 € (-3,04 %)     ELIA GROUP 137.600 € (-1,08 %)     FAGRON 23.850 € (+0,42 %)     HOME INVEST BE. 19.460 € (-0,21 %)     ACKERMANS V.HAAREN 268.600 € (+0,37 %)     ORANGE BELGIUM 21.700 € (-1,36 %)     ASCENCIO 51.500 € (-0,19 %)     VAN DE VELDE 29.600 € (-1,99 %)     KBC 122.350 € (+2,38 %)     JENSEN-GROUP 84.200 € (+0,72 %)     VASTNED 29.300 € (-0,85 %)     ECONOCOM GROUP 1.465 € (+1,03 %)     SIPEF 92.400 € (0,00 %)     CMB.TECH 13.620 € (+1,95 %)     ONWARD MEDICAL 2.485 € (+1,22 %)     SOFINA 229.200 € (+0,44 %)     WDP 22.100 € (-1,34 %)     ENERGYVISION 14.800 € (+0,27 %)     EVS 26.900 € (+0,19 %)     DECEUNINCK 2.175 € (+0,69 %)     GIMV 44.550 € (+0,11 %)     RETAIL ESTATES 67.600 € (-0,88 %)     ONTEX GROUP 2.210 € (-2,86 %)     BPOST 1.570 € (-1,13 %)     AGEAS 70.800 € (-0,42 %)     COLRUYT 37.940 € (-1,86 %)     GBL 77.200 € (+0,13 %)     UCB 243.900 € (+2,48 %)     WERELDHAVE BELGIUM 52.400 € (0,00 %)     VIOHALCO 17.220 € (+2,26 %)     SYENSQO 69.300 € (+0,22 %)     RECTICEL 12.020 € (+4,16 %)     TUBIZE-FIN 209.000 € (+2,65 %)     TESSENDERLO 20.500 € (-0,97 %)     TITAN S.A. 48.800 € (+1,33 %)     IBA 16.740 € (-0,36 %)     CIE BOIS SAUVAGE 301.000 € (+0,33 %)     SHURGARD 25.200 € (-3,45 %)     AEDIFICA 69.900 € (-0,71 %)     BIOTALYS 2.980 € (+0,17 %)     BREDERODE 103.000 € (0,00 %)  
   NSI N.V. 16.380 € (-1,56 %)     SHELL PLC 38.210 € (+0,79 %)     CAPITAL B 0.507 € (+6,13 %)     ATLAND 33.600 € (+0,30 %)     GENFIT 14.060 € (+3,69 %)     RELX 28.900 € (-2,69 %)     ABIONYX PHARMA 1.864 € (+1,19 %)     TKH GROUP 42.980 € (+1,27 %)     CORBION 19.410 € (-1,87 %)     MAISONS DU MONDE 0.188 € (-2,19 %)     LEGRAND 137.250 € (+1,59 %)     CREDIT AGRICOLE 18.105 € (+0,98 %)     TIKEHAU CAPITAL 17.360 € (-2,03 %)     CARBIOS 6.800 € (+23,41 %)     ARCELORMITTAL SA 57.860 € (-0,65 %)     ABN AMRO BANK N.V. 38.190 € (+2,00 %)     PROSUS 38.495 € (-3,70 %)     DSM FIRMENICH AG 83.980 € (-2,12 %)     WOLTERS KLUWER 60.000 € (-2,31 %)     PLANISWARE 20.000 € (-4,08 %)     ALTEN 55.300 € (-2,12 %)     BNP PARIBAS ACT.A 105.160 € (+1,80 %)     THEON INTERNAT 32.980 € (+2,93 %)     SEMCO TECHNOLOGIES 43.200 € (+4,10 %)     KAUFMAN ET BROAD 26.150 € (+1,16 %)     BILENDI 15.320 € (+2,68 %)     WORLDLINE 10.160 € (+2,77 %)     X-FAB 7.450 € (+7,74 %)     AEGON 8.020 € (+0,35 %)     ATOS GROUP 28.620 € (-5,23 %)     PEUGEOT INVEST 56.100 € (+1,08 %)     ASML HOLDING 1 593.400 € (+4,77 %)     AUBAY 53.000 € (-2,03 %)     IMCD 87.960 € (-0,43 %)     UNILEVER 53.440 € (-2,21 %)     SIRIUS MEDIA 0.640 € (-3,00 %)     BUREAU VERITAS 27.060 € (-1,53 %)     VICAT 60.800 € (-0,16 %)     AKZO NOBEL 57.160 € (-0,45 %)     INPOST 15.500 € (+0,26 %)     L'OREAL 378.750 € (-0,43 %)     BENETEAU 6.100 € (-0,97 %)     UMG 18.500 € (+0,27 %)     ORANGE 16.185 € (-1,52 %)     WENDEL 80.050 € (-0,87 %)     STMICROELECTRONICS 57.250 € (+4,26 %)     ARCADIS 34.380 € (-0,87 %)     BAM GROEP KON 11.670 € (+2,01 %)     JCDECAUX 21.860 € (-1,44 %)     LAKEFRONT BIOTHER. 25.640 € (-0,23 %)     AIR LIQUIDE 176.520 € (-0,66 %)     AXA 44.790 € (+0,07 %)     BASIC-FIT 30.680 € (-0,78 %)     CARREFOUR 16.545 € (-1,16 %)     HEINEKEN 76.920 € (-0,44 %)     SLIGRO FOOD GROUP 11.520 € (-3,52 %)     HEXAOM 27.200 € (-2,86 %)     KPN KON 4.247 € (-1,14 %)     GETLINK SE 18.790 € (+0,05 %)     MAUNA KEA TECH 0.170 € (+6,25 %)  
News Réglementées
16/07/2026 09:00

GIMM Festival brings leading microbiology experts to Lisbon to discuss emerging viruses, antimicrobial resistance and biological engineering

EQS-News: Fundação GIMM - Gulbenkian Institute for Molecular Medicine / Key word(s): Miscellaneous
GIMM Festival brings leading microbiology experts to Lisbon to discuss emerging viruses, antimicrobial resistance and biological engineering

16.07.2026 / 09:00 CET/CEST
The issuer is solely responsible for the content of this announcement.


Charles M. Rice (2020 Nobel Prize in Medicine), Bonnie Bassler, Yasmine Belkaid and Isabel Gordo are among the confirmed speakers.

LISBON, Portugal, July 16, 2026 /PRNewswire/ -- Bacteria are continuously evolving and becoming increasingly resistant to life-saving medicines. Understanding how microorganisms adapt, communicate and influence human health is now a global scientific priority. This will be one of the central themes of the second edition of the GIMM Festival, taking place in Lisbon from 17 to 19 September.

GIMM Fest Save the Date

Under the theme 'Microbes – The Questions of the Future', the festival will bring together internationally renowned researchers to explore the role of microorganisms in human health, biological evolution and ecosystem sustainability. The event aims to foster dialogue between science, society and biomedical innovation, at a time when challenges such as pandemics, antimicrobial resistance and environmental change are raising urgent new questions for research and policy.

The programme features some of the most influential names in contemporary microbiology:

  • Charles M. Rice (Rockefeller University), Nobel Prize winner in Medicine (2020), whose work led to the identification of the hepatitis C virus and enabled the development of effective antiviral treatments;
  • Yasmine Belkaid, President of the Institut Pasteur, recognised for her pioneering research on the microbiome and immune system interactions;
  • Bonnie Bassler (Princeton University), a leading expert in quorum sensing, the chemical communication process used by bacteria;
  • Isabel Gordo (GIMM), ERC Advanced Grant recipient, who studies bacterial evolution within the human body and the mechanisms behind antibiotic resistance.

Over three days, researchers and the public will engage in discussions on major scientific challenges of the 21st century, including host–microbe interactions and disease, antimicrobial resistance and bacterial evolution, emerging viruses and preparedness for future pandemics, as well as microorganism engineering and synthetic biology.

Antimicrobial resistance is considered by the World Health Organization one of the greatest threats to global health, with the potential to cause millions of deaths in the coming decades if no effective action is taken. At the same time, advances in microbiome research and the growing capacity to engineer microorganisms are transforming fields such as medicine, biotechnology and environmental sustainability, opening new possibilities for prevention, diagnosis and treatment.

"The microscopic world has a profound impact on our health, ecosystems and the future of biotechnology. The GIMM Festival aims to bring researchers and society closer together to discuss how these discoveries can shape the future," says Maria Manuel Mota, CEO of the Gulbenkian Institute for Molecular Medicine.

With the participation of world-leading scientists, including a Nobel laureate, the GIMM Festival positions Lisbon as an international hub for scientific debate, reinforcing its role as a meeting point for cutting-edge research and innovation in microbiology and global health.

The full programme and registration are available at www.gimmfest.pt.

About the Gulbenkian Institute for Molecular Medicine (GIMM)
The Gulbenkian Institute for Molecular Medicine (GIMM) is a biomedical research institute created through the merger of the Instituto Gulbenkian de Ciência (IGC) and the Instituto de Medicina Molecular João Lobo Antunes (iMM). With a strong commitment to advancing knowledge, developing innovative solutions for health and translating discoveries into real-world impact, GIMM aims to establish itself as a global leader in life sciences and biomedical research.
www.gimm.pt 

About the GIMM Festival
The GIMM Festival is an annual event in Lisbon that celebrates science as a driver of social transformation. Organised by GIMM, it brings together national and international experts to discuss the major challenges of global health, promoting the connection between cutting-edge research, biomedical innovation and society.
www.gimmfest.pt

Press Contacts
Rita Resendes  
Communications & Media Relations Manager, Fundação GIMM
rita.resendes@gimm.pt
+351 916 519 630

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/gimm-festival-brings-leading-microbiology-experts-to-lisbon-to-discuss-emerging-viruses-antimicrobial-resistance-and-biological-engineering-302826363.html

rt.gif?NewsItemId=EN05176&Transmission_Id=202607160255PR_NEWS_EURO_ND__EN05176&DateId=20260716


16.07.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2366628  16.07.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière